Sunday, Oct 04th

Last update07:17:40 PM GMT

You are here News Health FDA staff note deaths in Pfizer bone drug study

FDA staff note deaths in Pfizer bone drug study

E-mail Print PDF
A higher percentage of patients treated with an experimental Pfizer Inc drug for osteoporosis died during a clinical trial compared with a placebo, U.S. drug reviewers said in an analysis released on Thursday.

The higher proportion of deaths through five years was statistically significant only for the lowest dose of the drug called Fablyn, said Food and Drug Administration reviewers. More patients given Fablyn, which was co-developed with Ligand Pharmaceuticals Inc, also developed blood clots.


Most Recent Related Stories...

Doctors Without Borders leaves Kunduz after 'inexcusable' air strike

DWBInternational medical charity Doctors Without Borders (MSF) said Sunday it has withdrawn staff from the embattled...

Federal health program for Sept. 11 responders set to expire

First responders health coverageA law that provides medical monitoring and treatment for Sept. 11 first responders expires at midnight...

England, Wales ban smoking in cars with children inside

Smoking in car with childrenSmokers who light up in vehicles with children inside will face fines in England and Wales...

Medicare defrauded of $54M through ambulance transport services

Medicare ambulance fraudMedicare paid about $54 million in possibly fraudulent ambulance transport services in the first half of...
America's # 1 Enemy
Tee Shirt
& Help Support!
TVNL Tee Shirt
Conserve our Planet
& Help Support!
Get your 9/11 & Media
Deception Dollars
& Help Support!
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!